SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

The Federal Reserves rate hike is driving debate over SoFis exposure to higher funding costs, lending demand and credit risk versus potential benefits to its banking net-interest margins. Traders are divided, with many arguing the hike was already reflected in guidance and others warning that higher-for-longer rates could pressure the stock and fintech valuation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that states can regulate or ban sports-event contracts was viewed by traders as a regulatory win for DraftKings, potentially reducing competition from Kalshi and other prediction markets. The community remains divided, with some expecting stronger sportsbook economics while others note the ruling may face further appeals and could complicate DraftKings own prediction-market expansion.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of topline Phase 3 HLP003 results is driving attention after Helus completed enrollment in its pivotal MDD study ahead of schedule, with data expected in Q4 2026. Traders are also reacting positively to the new CEO and reported insider buying, while others remain cautious about clinical-readout risk and potential dilution.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

The failed or contested Salad and Go site acquisition is a major focus, with traders debating whether Dutch Bros avoided an expensive deal or lost a key expansion opportunity. Attention is also driven by the sharp selloff and valuation compression in a high-PE consumer stock, with bulls citing strong growth, store expansion and busy locations while bears point to weaker discretionary spending, competition, higher rates and possible dilution speculation.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA full approval of Fayuvi, Ultragenyxs gene therapy for Sanfilippo syndrome type A, is driving attention, with the company also receiving a Priority Review Voucher and preparing for commercialization. Traders are largely bullish on the new product and potential short covering, though some question the muted share-price reaction, limited patient population, adverse-effect monitoring, and Ultragenyxs cash burn.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Traders are focused on staged post-IPO lockup expirations and reported insider selling, which the community views as near-term supply pressure and a driver of sharp volatility. Bulls continue to cite Cerebras wafer-scale inference advantage and expanding cloud and data-center partnerships, while bears point to valuation, profitability, and broader AI-sector and macro risks.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

A reported purchase of 1 million GameStop shares by CEO Ryan Cohen is fueling bullish discussion, alongside speculation that company buybacks and heavy call positioning could add buying pressure. Traders are split between expecting a short squeeze, potentially aided by Roaring Kitty-related activity, and viewing the move as a low-volume, range-bound rally vulnerable to reversal.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp NEAR rally is drawing attention amid renewed interest in AI- and agent-focused crypto infrastructure, with traders also pointing to its perceived correlation with Zcash and broader altcoin rotation. Bulls view the move as a breakout and are adding positions, while others call it a temporary pump or liquidity grab and are watching resistance and short setups.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Long-term COMP360 trial data showing durable benefits, along with Compass Pathways anticipated rolling NDA submission and upcoming FDA discussions, is driving attention. Traders are broadly bullish on the companys first-mover position and potential launch, while others remain cautious about regulatory, reimbursement, commercialization and competitive risks.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing shares are drawing attention after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected because of wing-production constraints, while also tempering expectations for a near-term China order and citing slower widebody ramp-up issues. Traders largely reacted bearishly with a sharp selloff, though bulls argue the move is an overreaction given Boeings backlog, deliveries, defense contracts and expected MAX 10 certification; potential SPEEA labor disruption remains an additional concern.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FRSPF I&#39;m confused,  is there ever going to be a switch to PHOS now that they are a part of the NSYE? I am hearing a 1 for 10 split

CB, Structural Biologist

StockTwits Web

First Phosphate Corp

 I'm confused,  is there ever going to be a switch to PHOS now that they are a part of the NSYE? I am hearing a 1 for 10 split

Steven Salloway

@Sandymax   etrade told me it would cost me a nickel a share to have them converted. Plus their fee that wasn&#39;t to much.

StockTwits For Android 

   etrade told me it would cost me a nickel a share to have them converted. Plus their fee that wasn't to much.

wood

@Sandymax and yes  10 common shares for 1 adr

@Sandymax is it worth converting? Or just keep them as is? What’s the pros and cons

StockTwits for iOS

 is it worth converting? Or just keep them as is? What’s the pros and cons